MedTrace Logo

Enhancing Consent for Alzheimer's Research

NCT00453544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2023-06-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of an enhanced consent procedure for patients with mild-to-moderate Alzheimer disease, and to identify factors and patient characteristics that predict the degree to which enhanced consent is more beneficial than routine consent procedures.

Conditions

  • Alzheimer Disease

Interventions

OTHER

Enhanced Consent Procedure

This is a procedure involving use of multimedia materials, as well as standard review with research staff, to see if the research consent procedure can be improved

OTHER

Routine Consent Procedure

This is a procedure designed to be in accord with standard research consent practices (and lacks multimedia aids)

Sponsors & Collaborators

Principal Investigators

  • Barton W. Palmer, PhD · UCSD

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00453544 on ClinicalTrials.gov